Tralokinumab Side Effects

Medically reviewed by Drugs.com. Last updated on Jul 5, 2024.

Applies to tralokinumab: subcutaneous solution.

Precautions

It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly. Blood tests may be needed to check for unwanted effects.

This medicine may cause serious allergic reactions, including anaphylaxis and angioedema, which can be life-threatening and require immediate medical attention. Tell your doctor right away if you have chest tightness, cough, difficulty swallowing, dizziness, fast heartbeat, hives, itching, skin rash, large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue, trouble breathing, or unusual tiredness or weakness after using this medicine.

Check with your doctor right away if you have redness, irritation, or itching the of eye, eyelid, or inner lining of the eyelid. These could be symptoms of eye problems, including conjunctivitis or keratitis.

Do not have any live vaccines (immunizations) while you are being treated with tralokinumab-ldrm. Check with your doctor before having any vaccines.

Serious side effects of tralokinumab

Along with its needed effects, tralokinumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking tralokinumab:

Other side effects of tralokinumab

Some side effects of tralokinumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For healthcare professionals

Applies to tralokinumab: subcutaneous solution.

Respiratory adverse events

• Very common (10% or more): Upper respiratory tract infections (included upper respiratory tract infection, viral upper respiratory tract infection, pharyngitis, nasopharyngitis, common cold; up to 30%)^[Ref]

Ocular

• Very common (10% or more): Conjunctivitis (included conjunctivitis, allergic conjunctivitis; up to 13.6%)
• Common (1% to 10%): Allergic conjunctivitis
• Uncommon (0.1% to 1%): Keratitis (including keratoconjunctivitis, atopic keratoconjunctivitis, ulcerative keratitis)

Immunologic

• Common (1% to 10%): Anti-drug antibody
• Uncommon (0.1% to 1%): Neutralizing antibodies

Hematologic

• Common (1% to 10%): Eosinophilia (included eosinophilia, increased eosinophil count)

Dermatologic

• Uncommon (0.1% to 1%): Eczema herpeticum^[Ref]

Local

• Very common (10% or more): Injection site reactions (included pain, swelling, erythema/redness; up to 11.1%)^[Ref]

See also:

Frequently asked questions

• What are the most common skin conditions? (with photos)

Further information

Tralokinumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer